Management of patient presenting with breast fibroadenoma and medullary thyroid cancer in a young male: A case report and review of the literature

• Published in: Annals of medicine and surgery (2012) Vol. 80; p. 104298
• Main Authors: Wondwosen, Mekete, Bacha, Ayantu, Nibret, Yonas, Tantu, Temesgen, Zewdu, Dereje
• Format: Report
• Language: English
• Published: 01-08-2022
• ISSN: 2049-0801; 2049-0801
• DOI: 10.1016/j.amsu.2022.104298

Introduction and importanceFibroadenoma of the male breast is a rarely diagnosed lesion that often occurs concurrently with gynecomastia and the intake of medications that alter sex hormone levels. Herein, we report the first case of fibroadenoma of the male breast, presenting with medullary thyroid cancer. In addition, we reviewed the current management strategies for fibroadenoma of the male breast in the literature. Case presentationA 25-year-old male patient presented to our surgical unit with medullary thyroid cancer (MTC). The physical examination revealed an unnoticed lump in his left breast. We delayed the planned thyroid surgery to determine whether the breast mass was associated with metastasis from MTC. We performed pathological tests from excised breast mass and confirmed the diagnosis of fibroadenoma. After confirming the benign nature of the breast mass, the patient underwent total thyroidectomy with selective neck dissection for MTC. Clinical discussionFibroadenoma of the male breast was diagnosed based on clinical presentation and histopathological findings. Fibroadenoma of the male breast is a rarely diagnosed lesion: and is often associated with gynecomastia and altered serum sex hormone level. The presentation of this case without those concurrences is even rarer, as revealed in our case. The management for suspected fibroadenoma of the male breast presented with MTC should include delaying the thyroid surgery to rule out the presence of malignancy and metastasis. ConclusionThe finding indicates that fibroadenoma can be considered a differential diagnosis in the male breast even in the absence of those concurrences. The timely diagnosis and orderly management of fibroadenoma of the male breast and MTC could help to improve the patient outcome.